"Dedicated to Man's Fight against Disease and Pain"− upholding this corporate philosophy comes uppermost in the priorities of the Ono Pharmaceutical Group.

Steadfast in our resolve, we style ourselves as a "Global Specialty Pharma" following the path of an R&D-oriented international pharmaceutical company. Our emphasis is on creating innovative medicines that are globally viable.

ONO PHARMA TAIWAN CO.,LTD. (“OPTW”) located in Taipei was established in 2014 as a wholly-owned subsidiary of ONO PHARMACEUTICAL CO., LTD. (Head Office: Osaka City, Japan).

While OPTW continues to support for promotion of the ONO’s licensee in scientific aspect in Taiwan, OPTW plans to commercialize specialty products such as anti-cancer agents in the future. OPTW has committed its effort to obtain a further understanding of and to increase the use of ONO’s products in Taiwan.